A detailed history of Barclays PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Barclays PLC holds 31,286 shares of ZLAB stock, worth $556,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,286
Previous 600 5114.33%
Holding current value
$556,265
Previous $16,000 3037.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $489,441 - $822,384
30,686 Added 5114.33%
31,286 $502,000
Q2 2023

Aug 03, 2023

SELL
$25.3 - $39.67 $1.82 Million - $2.85 Million
-71,947 Reduced 99.17%
600 $17,000
Q1 2023

May 04, 2023

BUY
$30.21 - $48.1 $548,220 - $872,870
18,147 Added 33.36%
72,547 $2.41 Million
Q4 2022

Feb 13, 2023

SELL
$22.28 - $38.71 $2.09 Million - $3.62 Million
-93,632 Reduced 63.25%
54,400 $1.67 Million
Q3 2022

Nov 03, 2022

SELL
$34.2 - $51.69 $3.91 Million - $5.91 Million
-114,384 Reduced 43.59%
148,032 $5.06 Million
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $2.96 Million - $6.36 Million
127,930 Added 95.13%
262,416 $9.1 Million
Q1 2022

May 16, 2022

BUY
$27.77 - $64.4 $3.73 Million - $8.66 Million
134,486 New
134,486 $5.91 Million
Q3 2020

Nov 12, 2020

SELL
$73.3 - $89.48 $1.55 Million - $1.89 Million
-21,129 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$48.82 - $82.53 $636,075 - $1.08 Million
13,029 Added 160.85%
21,129 $1.74 Million
Q1 2020

May 13, 2020

BUY
$39.1 - $62.9 $180,055 - $289,654
4,605 Added 131.76%
8,100 $417,000
Q4 2019

Feb 10, 2020

SELL
$29.79 - $43.06 $16,563 - $23,941
-556 Reduced 13.73%
3,495 $145,000
Q3 2019

Nov 14, 2019

BUY
$30.47 - $37.65 $102,744 - $126,955
3,372 Added 496.61%
4,051 $131,000
Q2 2019

Aug 14, 2019

BUY
$25.73 - $35.79 $17,470 - $24,301
679 New
679 $23,000
Q1 2019

May 15, 2019

SELL
$21.71 - $31.54 $60,570 - $87,996
-2,790 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$14.95 - $24.72 $41,710 - $68,968
2,790 New
2,790 $65,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.74B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.